Semler Scientific (NASDAQ:SMLR) Releases Quarterly Earnings Results, Beats Expectations By $0.35 EPS

Semler Scientific (NASDAQ:SMLR) announced its quarterly earnings results on Monday. The company reported $0.72 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.37 by $0.35, Zacks reports. The firm had revenue of $13.51 million for the quarter. Semler Scientific had a net margin of 27.00% and a return on equity of 20.93%.

Semler Scientific Stock Performance

NASDAQ SMLR traded up $1.11 on Wednesday, hitting $40.11. The stock had a trading volume of 826,974 shares, compared to its average volume of 192,256. The firm has a 50-day moving average of $26.37 and a 200-day moving average of $28.81. The company has a market capitalization of $280.45 million, a price-to-earnings ratio of 19.57 and a beta of 0.92. Semler Scientific has a 52-week low of $20.88 and a 52-week high of $53.38.

Insider Activity

In related news, CEO Douglas Murphy-Chutorian sold 10,000 shares of Semler Scientific stock in a transaction on Thursday, August 29th. The stock was sold at an average price of $28.35, for a total transaction of $283,500.00. Following the completion of the sale, the chief executive officer now owns 60,220 shares of the company’s stock, valued at approximately $1,707,237. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 30.20% of the company’s stock.

About Semler Scientific

Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company’s products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient’s vascular condition.